Subcutaneous apomorphine in Parkinson's disease

被引：19

作者：

Chaudhuri, KR

Clough, C

机构：

[1] Kings Coll Hosp London, Reg Neurosci Ctr, Movement Disorders Unit, London SE5 9RS, England

[2] Inst Psychiat, London SE5 9RS, England

[3] Univ Hosp Lewisham, London SE5 9RS, England

来源：

BMJ-BRITISH MEDICAL JOURNAL | 1998年 / 316卷 / 7132期

关键词：

D O I：

10.1136/bmj.316.7132.641

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：641 / 641

页数：1

共 10 条

[1] CLINICAL USEFULNESS OF APOMORPHINE IN MOVEMENT-DISORDERS [J].

COLOSIMO, C ;

MERELLO, M ;

ALBANESE, A .

CLINICAL NEUROPHARMACOLOGY, 1994, 17 (03) :243-259

[2]

COLZI A, 1997, MOV DISORD S1, V12, pP428

[3]

CORSINI GU, 1979, LANCET, V1, P954

[4] SIMILARITIES BETWEEN NEUROLOGIC EFFECTS OF L-DOPA AND OF APOMORPHINE [J].

COTZIAS, GC ;

PAPAVASILIOU, PS ;

FEHLING, C ;

KAUFMAN, B ;

MENA, I .

NEW ENGLAND JOURNAL OF MEDICINE, 1970, 282 (01) :31-+

[5]

Ellis C, 1997, Parkinsonism Relat Disord, V3, P103, DOI 10.1016/S1353-8020(97)00009-6

[6] ON-OFF FLUCTUATIONS IN PARKINSONS-DISEASE - A CLINICAL AND NEURO-PHARMACOLOGICAL STUDY [J].

HARDIE, RJ ;

LEES, AJ ;

STERN, GM .

BRAIN, 1984, 107 (JUN) :487-506

[7] SUBCUTANEOUS APOMORPHINE IN PARKINSONS-DISEASE - RESPONSE TO CHRONIC ADMINISTRATION FOR UP TO 5 YEARS [J].

HUGHES, AJ ;

BISHOP, S ;

KLEEDORFER, B ;

TURJANSKI, N ;

FERNANDEZ, W ;

LEES, AJ ;

STERN, GM .

MOVEMENT DISORDERS, 1993, 8 (02) :165-170

[8]

SCHWAB RS, 1951, T AM NEUROL ASSOC, P251

[9]

STIBE CMH, 1988, LANCET, V1, P403

[10] THE DOPAMINE-D-1 AGONIST SKF-81297 AND THE DOPAMINE-D-2 AGONIST LY-171555 ACT SYNERGISTICALLY TO STIMULATE MOTOR BEHAVIOR OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-LESIONED PARKINSONIAN RHESUS-MONKEYS [J].

VERMEULEN, RJ ;

DRUKARCH, B ;

SAHADAT, MCR ;

GOOSEN, C ;

WOLTERS, EC ;

STOOF, JC .

MOVEMENT DISORDERS, 1994, 9 (06) :664-672

← 1 →